Nattokinase Benefits: Circulation, Fibrin, Evidence, and Safety

Nattokinase has become one of the most discussed systemic enzymes in cardiovascular and longevity medicine. The interest is understandable: circulation, vascular function, and fibrin regulation are central to long-term cardiovascular health.

Unlike a standard digestive enzyme, nattokinase is used for its potential systemic effects. Research has examined its influence on fibrinolytic activity, coagulation markers, blood pressure, arterial function, and cardiovascular risk factors.*

The most useful way to understand nattokinase is neither as a miracle “natural blood thinner” nor as an ingredient without value. It is a biologically active enzyme with encouraging early human evidence, practical applications for selected individuals, and important medication considerations.

What Is Nattokinase?

Nattokinase is a proteolytic enzyme produced during the fermentation of soybeans by Bacillus subtilis var. natto. It was originally identified in natto, a traditional Japanese fermented soybean food.

Nattokinase is described as fibrinolytic because it can influence the breakdown of fibrin and several components of the body’s fibrinolytic system.* This activity has led to its use in supplements intended to support circulation, vascular function, and normal fibrin balance.*

Despite its name, nattokinase is not vitamin K2. Natto naturally contains vitamin K2, but a purified nattokinase supplement should not be assumed to provide vitamin K2 unless it appears on the product label.

Why Fibrin Balance Matters

Fibrin is an essential structural protein formed during normal blood clotting. It helps stabilize a clot following injury. As healing progresses, the body uses fibrinolysis to break down and remodel the fibrin structure.

Healthy vascular function depends on maintaining an appropriate balance between clot formation and clot breakdown. Nattokinase is studied for its potential to support this natural fibrinolytic balance and healthy circulation.*

This does not mean that fibrin is inherently harmful or that it should be eliminated. The goal is normal regulation within a carefully controlled physiological system.

Potential Benefits of Nattokinase

Fibrinolytic Activity

Laboratory and small human studies demonstrate that nattokinase can influence fibrinolytic activity and markers related to the breakdown of fibrin.*

In a double-blind crossover study, 12 healthy men received a single 2,000-FU dose of nattokinase or placebo. Nattokinase produced measurable changes in D-dimer, fibrin-degradation products, activated partial thromboplastin time, factor VIII activity, and antithrombin.

The values remained within normal laboratory ranges, suggesting that nattokinase can influence these pathways without producing extreme changes under the conditions studied.

Healthy Blood Pressure

A systematic review and meta-analysis of six randomized trials involving 546 participants found modest average reductions in systolic and diastolic blood pressure with nattokinase supplementation.*

The blood-pressure findings are clinically interesting because vascular tone and blood pressure are major contributors to cardiovascular and cognitive aging. Nattokinase may therefore have a role as supplemental support within a broader blood-pressure strategy.*

Circulation and Vascular Wellness

Through its effects on fibrinolytic and vascular pathways, nattokinase may support healthy circulation and normal blood flow.* This is the primary reason it is considered in systemic enzyme and cardiovascular-support protocols.

Its role is best understood as complementary. Exercise, blood-pressure control, metabolic health, nutrition, sleep, smoking avoidance, and appropriate lipid management remain the foundation of vascular health.

Understanding Fibrinolytic Units

Nattokinase potency is commonly expressed in fibrinolytic units, abbreviated FU. Milligrams describe the weight of an ingredient, while FU describe its measured enzyme activity in a standardized laboratory assay.

This distinction matters because two products containing the same milligram amount may provide different levels of enzymatic activity.

A daily amount of 2,000 FU has been used in several human studies. The appropriate product and dose should still be selected according to the individual’s health history, medications, bleeding risk, and reason for use.

What Longer-Term Research Found

A three-year randomized, double-blind, placebo-controlled trial evaluated 2,000 FU of nattokinase daily in 265 healthy adults without clinical cardiovascular disease. The study did not find significant improvement in carotid intima-media thickness, arterial stiffness, blood pressure, laboratory risk markers, or cognitive decline.

This result provides useful context. The participants were generally healthy and at relatively low cardiovascular risk, so the findings may not answer every question about nattokinase in populations with different risk profiles. It does show that measurable fibrinolytic activity should not automatically be interpreted as proven plaque regression or protection from cardiovascular events.

Current evidence supports describing nattokinase as a promising circulation and fibrinolytic-support ingredient with developing clinical research.* Larger trials are still needed to determine whether its biological effects translate into fewer heart attacks, strokes, blood clots, or other long-term outcomes.

Nattokinase in Longevity Medicine

Nattokinase may be considered by selected adults seeking additional support for circulation, fibrin balance, or vascular wellness after medication use and bleeding risk have been reviewed.*

In a longevity-medicine model, it may be considered alongside:

• Blood-pressure assessment and treatment
• ApoB, LDL-C, triglycerides, and lipoprotein(a)
• Glucose regulation and insulin resistance
• Inflammatory and metabolic risk
• Exercise and body composition
• Mediterranean-style nutrition
• Sleep and recovery
• Carotid ultrasound, coronary calcium, or coronary CT imaging when appropriate

This systems-based approach places nattokinase where it belongs: as one possible supplement within a much broader cardiovascular and healthy-aging strategy.*

Nattokinase and Other Systemic Enzymes

Nattokinase is sometimes discussed alongside serrapeptase and fungal-derived systemic enzyme preparations, but these ingredients are not interchangeable.

• Nattokinase is produced during bacterial fermentation of soybeans used to make natto.
• Nattozimes® is a fungal-derived protease preparation from Aspergillus oryzae.
• Serrapeptase, also called serratiopeptidase, is a separate proteolytic enzyme.
• Serrazimes® is a fungal-derived protease preparation from Aspergillus melleus.

RetzlerRx® Systemic Enzyme Complex contains Nattozimes® and Serrazimes®. It is formulated to support systemic enzyme activity, circulation, inflammatory balance, and recovery,* but it does not contain nattokinase or serrapeptase.

Safety and Medication Considerations

Because nattokinase may influence fibrinolysis and coagulation, consult your healthcare professional before use if you take anticoagulant or antiplatelet medication, have a bleeding or clotting disorder, are pregnant or breastfeeding, have a soy allergy, or are preparing for surgery or an invasive procedure. Nattokinase should not replace prescribed anticoagulation or be used to self-treat a suspected blood clot.

The HormoneSynergy® Perspective

Nattokinase is a biologically interesting enzyme with measurable fibrinolytic activity and emerging human evidence for circulation and blood-pressure support.* It may be a reasonable adjunct for selected adults when the intended purpose, medications, and bleeding risk have been considered.

It is not the foundation of cardiovascular prevention, but it does not need to be dismissed simply because the evidence is still developing. The practical approach is to use it selectively, understand what it can reasonably support, and keep it within a comprehensive plan built around measurable cardiovascular and metabolic risk.

Related HormoneSynergy® Resources

Selected Clinical Resources

• Nattokinase Atherothrombotic Prevention Study: Randomized, Double-Blind, Placebo-Controlled Trial
• Nattokinase Supplementation and Cardiovascular Risk Factors: Systematic Review and Meta-Analysis
• Single-Dose Nattokinase and Fibrinolysis and Coagulation Markers

Frequently Asked Questions

What is nattokinase?

Nattokinase is a fibrinolytic protease produced during the bacterial fermentation of soybeans used to make natto.

What does nattokinase support?

Nattokinase may support fibrinolytic activity, healthy circulation, normal fibrin balance, and healthy blood pressure.*

What does FU mean on a nattokinase label?

FU means fibrinolytic units, a laboratory measure of enzyme activity.

Is nattokinase a blood thinner?

It is not an FDA-approved anticoagulant medication, but it can influence fibrinolytic and coagulation pathways. People taking medication that affects clotting should obtain professional guidance before using it.

Can nattokinase be taken with anticoagulant medication?

Do not combine nattokinase with anticoagulant or antiplatelet medication without approval from the prescribing healthcare professional.

Is Nattozimes® the same as nattokinase?

No. Nattozimes® is a fungal-derived protease preparation from Aspergillus oryzae. It is not nattokinase.

*Important Notice: Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Information provided is educational and should not replace personalized medical advice.

For best results, supplements should be used as part of a comprehensive health strategy including nutrition, exercise, restorative sleep, stress management, and appropriate medical evaluation when necessary.